BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 25772768)

  • 61. Short-term changes in hormonal profiles after laparoscopic ovarian laser evaporation compared with diagnostic laparoscopy for PCOS.
    Hendriks ML; König T; Korsen T; Melgers I; Dekker J; Mijatovic V; Schats R; Hompes PG; Homburg R; Kaaijk EM; Twisk JW; Lambalk CB
    Hum Reprod; 2014 Nov; 29(11):2544-52. PubMed ID: 25267790
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens.
    Gleicher N; Kushnir VA; Darmon SK; Wang Q; Zhang L; Albertini DF; Barad DH
    J Steroid Biochem Mol Biol; 2017 Mar; 167():144-152. PubMed ID: 27993552
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum levels of antimüllerian hormone in women with regular menstrual cycles.
    Zec I; Tislarić-Medenjak D; Bukovec-Megla Z; Harni V; Kusić Z
    Acta Clin Croat; 2010 Dec; 49(4):405-9. PubMed ID: 21830451
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antimüllerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cells.
    Chang HM; Klausen C; Leung PC
    Fertil Steril; 2013 Aug; 100(2):585-92.e1. PubMed ID: 23663993
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A; Abdelmeged A; El-Adawy AR; Eissa MK; Shaw RW; Amer SA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Concentration of anti-Müllerian hormone and inhibin-B in relation to steroids and age in follicular fluid from small antral human follicles.
    Yding Andersen C; Rosendahl M; Byskov AG
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2344-9. PubMed ID: 18381582
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gonadotropin releasing hormone antagonists suppress aromatase and anti-Müllerian hormone expression in human granulosa cells.
    Winkler N; Bukulmez O; Hardy DB; Carr BR
    Fertil Steril; 2010 Oct; 94(5):1832-9. PubMed ID: 19896656
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
    Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
    Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Anti-Mullerian hormone and polycystic ovary syndrome].
    Catteau-Jonard S; Dewailly D
    Gynecol Obstet Fertil; 2011 Sep; 39(9):514-7. PubMed ID: 21840745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.
    Rey R; Lordereau-Richard I; Carel JC; Barbet P; Cate RL; Roger M; Chaussain JL; Josso N
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1220-6. PubMed ID: 8077315
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with advancing age.
    Gleicher N; Kushnir VA; Darmon SK; Wang Q; Zhang L; Albertini DF; Barad DH
    Endocrine; 2018 Mar; 59(3):661-676. PubMed ID: 29305800
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of testosterone on ovulatory function in transmasculine individuals.
    Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
    Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Testosterone and androstenedione are positively associated with anti-Müllerian hormone in premenopausal women.
    Islam RM; Bell RJ; Skiba MA; Davis SR
    Clin Endocrinol (Oxf); 2021 Nov; 95(5):752-759. PubMed ID: 34524701
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.
    Kinnear HM; Constance ES; David A; Marsh EE; Padmanabhan V; Shikanov A; Moravek MB
    Hum Reprod; 2019 Oct; 34(10):2009-2017. PubMed ID: 31585007
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals.
    Meriggiola MC; Armillotta F; Costantino A; Altieri P; Saad F; Kalhorn T; Perrone AM; Ghi T; Pelusi C; Pelusi G
    J Sex Med; 2008 Oct; 5(10):2442-53. PubMed ID: 18624972
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ANTIMÜLLERIAN HORMONE AS INDICATOR OF OVARIAN DYSFUNCTION.
    Bothou A; Koutlaki N; Iatrakis G; Mastorakos G; Tsikouras P; Liberis V; Galazios G; Liberis A; Lykeridou A; Zervoudis S
    Acta Endocrinol (Buchar); 2017; 13(2):237-245. PubMed ID: 31149181
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Circulating nitric oxide levels increase after anti-androgen treatment in male-to-female transsexuals.
    Valenti S; Fazzuoli L; Giusti M
    J Endocrinol Invest; 2003 Jun; 26(6):522-6. PubMed ID: 12952365
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.
    Jung S; Allen N; Arslan AA; Baglietto L; Brinton LA; Egleston BL; Falk R; Fortner RT; Helzlsouer KJ; Idahl A; Kaaks R; Lundin E; Merritt M; Onland-Moret C; Rinaldi S; Sánchez MJ; Sieri S; Schock H; Shu XO; Sluss PM; Staats PN; Travis RC; Tjønneland A; Trichopoulou A; Tworoger S; Visvanathan K; Krogh V; Weiderpass E; Zeleniuch-Jacquotte A; Zheng W; Dorgan JF
    Fertil Steril; 2017 Apr; 107(4):1012-1022.e2. PubMed ID: 28366409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.